A review of the law on second medical use patent claims:Have the English Courts gone too far in restricting second medical use claims?

By Binns R.   Döring M.  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 2, 2001-02 ,pp. : 323-332

Informa Healthcare

Access to resources Recommend Favorite

The Jean Chrétien Pledge to Africa Act: patent law and humanitarian aid

By Rimmer Matthew  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 7, 2005-07 ,pp. : 889-909

Informa Healthcare

Access to resources Recommend Favorite

Racial disparity in HIV trials, experimental drug use

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 362, 2002-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Use of an anti-CD200 antibody for prolonging the survival of allografts: a patent evaluation of WO2012106634A1

By Rygiel Tomasz P   Luijk Bart   Meyaard Linde  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 3, 2013-03 ,pp. : 389-392

Informa Healthcare

Access to resources Recommend Favorite

Use of a peptide enhancing the ability of radiation therapy to kill cancer cells: a patent evaluation of WO2012016918

By Xu Jing   Wei Qichun  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 12, 2012-12 ,pp. : 1485-1487

Informa Healthcare

Access to resources Recommend Favorite